Warfarin: here's the fair price
This is what US pharmacies pay, on average, for warfarin. Use it to spot a fair cash price, and feel good about asking for one.
Warfarin Sodium 7.5 Mg Tablet
A fair cash price is usually this cost plus a dispensing fee. If your quote is many times higher, ask about a generic, another pharmacy, or a cash discount.
Ask for generic Warfarin Sodium 7.5 Mg Tablet. Pharmacies pay about $2.63 for 30. Ask your pharmacy for its cash price and compare it with your copay. A fair cash price is close to this cost plus a dispensing fee.
Source: CMS NADAC as of 2026-11-04. Ask your prescriber or pharmacist whether a generic is right for you.
Source: CMS NADAC weekly file as of 2026-11-04. Median across NDCs with the same description. Public domain.
Your ZIP and location stay in your browser. We never store them.
Every strength and form
| Product | Pharmacy cost | 30 count | Effective |
|---|---|---|---|
| WARFARIN SODIUM 7.5 MG TABLETGeneric | $0.09 per tablet or capsule | $2.63 | 10/21/2026 |
| WARFARIN SODIUM 5 MG TABLETGeneric | $0.09 per tablet or capsule | $2.67 | 10/21/2026 |
| WARFARIN SODIUM 6 MG TABLETGeneric | $0.10 per tablet or capsule | $2.86 | 10/21/2026 |
| WARFARIN SODIUM 2 MG TABLETGeneric | $0.10 per tablet or capsule | $2.86 | 10/21/2026 |
| WARFARIN SODIUM 2.5 MG TABLETGeneric | $0.10 per tablet or capsule | $2.90 | 10/21/2026 |
| WARFARIN SODIUM 4 MG TABLETGeneric | $0.10 per tablet or capsule | $3.02 | 10/21/2026 |
| WARFARIN SODIUM 3 MG TABLETGeneric | $0.10 per tablet or capsule | $3.02 | 10/21/2026 |
| WARFARIN SODIUM 1 MG TABLETGeneric | $0.10 per tablet or capsule | $3.07 | 10/21/2026 |
| WARFARIN SODIUM 10 MG TABLETGeneric | $0.11 per tablet or capsule | $3.27 | 10/21/2026 |
Source: CMS NADAC, as of 2026-11-04. National average acquisition cost, not a retail quote.
Label basics
What it is used for (FDA label)
1 INDICATIONS AND USAGE Warfarin sodium tablets are indicated for: Prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). Prophylaxis and treatment of thromboembolic complications associated with atrial fibrillation (AF) and/or cardiac valve replacement. Reduction in the risk of death, recurrent myocardial infarction (MI), and thromboembolic events such as stroke or systemic embolization after myocardial infarction. Limitations of Use Warfarin sodium tablets have no direct effect on an established thrombus, nor does it reverse ischemic tissue damage. Once a thrombus has occurred, however, the goals of anticoagulant treatment are to prevent further...
Common side effects (FDA label)
6 ADVERSE REACTIONS The following serious adverse reactions to warfarin sodium are discussed in greater detail in other sections of the labeling: Hemorrhage [see Boxed Warning , Warnings and Precautions (5.1) , and Overdosage (10) ] Tissue Necrosis [see Warnings and Precautions (5.2) ] Calciphylaxis [see Warnings and Precautions (5.3) ] Acute Kidney Injury [see Warnings and Precautions (5.4) ] Systemic Atheroemboli and Cholesterol Microemboli [see Warnings and Precautions (5.5) ] Limb Ischemia, Necrosis, and Gangrene in Patients with HIT and HITTS [see Warnings and Precautions (5.6) ] Other...
Drug interactions (from the label)
7 DRUG INTERACTIONS Concomitant use of drugs that increase bleeding risk, antibiotics, antifungals, botanical (herbal) products, and inhibitors and inducers of CYP2C9, 1A2, or 3A4. ( 7 ) Consult labeling of all concurrently used drugs for complete information about interactions with warfarin sodium or increased risks for bleeding. (7) 7.1 General Information Drugs may interact with warfarin sodium through pharmacodynamic or pharmacokinetic mechanisms. Pharmacodynamic mechanisms for drug interactions with warfarin sodium are synergism (impaired hemostasis, reduced clotting factor synthesis), competitive antagonism (vitamin K), and alteration of the physiologic control loop for vitamin K...
Warnings (from the label)
5 WARNINGS AND PRECAUTIONS Tissue necrosis: Necrosis or gangrene of skin or other tissues can occur, with severe cases requiring debridement or amputation. Discontinue warfarin sodium and consider alternative anticoagulants if necessary. (5.2) Calciphylaxis: Fatal and serious cases have occurred. Discontinue warfarin sodium and consider alternative anticoagulation therapy. ( 5.3 ) Acute kidney injury may occur during episodes of excessive anticoagulation and hematuria. ( 5.4 ) Systemic atheroemboli and cholesterol microemboli: Some cases have progressed to necrosis or death. Discontinue warfarin sodium if such emboli occur. ( 5.5 ) Heparin-induced thrombocytopenia (HIT): Initial therapy...
Source: FDA drug label via openFDA, label effective 2026-06-25. Full label on DailyMed. Excerpts are verbatim and truncated. Read the full label and ask your pharmacist.